本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

228.00
-6.9900-2.97%
成交量:95.01万
成交额:2.18亿
市值:140.67亿
市盈率:-51.61
高:236.83
开:233.99
低:226.48
收:234.99
52周最高:242.00
52周最低:124.06
股本:6,169.52万
流通股本:6,008.34万
量比:1.42
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
净资产收益率:-818.43%
总资产收益率:-6.86%
市净率:-73.20
市盈率(LYR):-51.61

数据加载中...

2026/02/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities